data_1la0_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1la0 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.5 mmt . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.051 0.453 . . . . 0.0 110.264 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -65.34 92.83 0.13 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.614 -0.679 . . . . 0.0 110.021 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 56.23 107.09 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.584 -0.697 . . . . 0.0 110.71 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 14.9 mt -90.82 -26.14 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.384 -0.822 . . . . 0.0 110.244 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -93.06 -44.41 8.41 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.452 -0.78 . . . . 0.0 110.506 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -77.1 -18.66 57.81 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.614 -0.679 . . . . 0.0 110.888 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.26 -54.39 44.7 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.225 -0.922 . . . . 0.0 110.287 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.01 -45.52 92.51 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.578 -0.701 . . . . 0.0 110.118 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 62.8 t -58.63 -60.13 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.627 -0.671 . . . . 0.0 109.871 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -60.57 -22.65 63.92 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.505 -0.747 . . . . 0.0 110.011 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -108.0 55.22 0.65 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.54 -0.725 . . . . 0.0 109.874 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 19.2 mt -90.99 139.05 31.13 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.559 -0.713 . . . . 0.0 110.257 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.1 m -87.04 153.99 21.11 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.565 -0.709 . . . . 0.0 109.648 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -67.4 -24.75 65.7 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.551 -0.718 . . . . 0.0 110.76 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -73.01 -45.86 55.42 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.365 -0.834 . . . . 0.0 110.701 -179.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.404 ' O ' ' CD2' ' A' ' 20' ' ' PHE . 9.9 pt20 -74.22 -23.8 59.23 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.361 -0.837 . . . . 0.0 110.323 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.0 tttm -65.51 -44.15 87.86 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.495 -0.753 . . . . 0.0 110.29 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 26.0 p30 -64.49 -21.72 66.75 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.415 -0.803 . . . . 0.0 110.446 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -86.44 -39.67 16.09 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.429 -0.795 . . . . 0.0 109.852 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.404 ' CD2' ' O ' ' A' ' 16' ' ' GLN . 20.7 m-85 -69.27 -36.27 76.92 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.699 -0.626 . . . . 0.0 110.045 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.7 mtpt -55.82 -40.93 73.46 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.506 -0.746 . . . . 0.0 110.423 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.43 -48.51 22.44 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.615 -0.678 . . . . 0.0 109.933 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.403 ' O ' ' CD2' ' A' ' 27' ' ' PHE . . . -62.87 -34.5 77.5 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.661 -0.65 . . . . 0.0 109.915 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.502 ' CZ ' ' CD1' ' A' ' 77' ' ' PHE . 5.7 m-30 -75.53 -29.78 59.56 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.606 -0.684 . . . . 0.0 109.756 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -69.73 -22.24 63.4 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.707 -0.621 . . . . 0.0 110.652 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 41.2 mt -86.82 -38.11 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.305 -0.872 . . . . 0.0 110.198 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.423 ' CZ ' HG21 ' A' ' 44' ' ' VAL . 17.0 m-85 -59.33 -22.09 60.76 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.519 -0.738 . . . . 0.0 110.551 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.5 m -95.2 36.4 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.384 -0.822 . . . . 0.0 110.478 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.6 mt -89.91 113.1 24.67 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.442 -0.786 . . . . 0.0 109.976 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 110.36 -29.2 9.34 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.51 -163.73 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.613 -0.934 . . . . 0.0 110.53 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -116.11 -67.58 0.98 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.619 -0.675 . . . . 0.0 110.317 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -73.31 -43.2 61.32 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.547 -0.721 . . . . 0.0 110.225 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 134.74 54.95 0.07 OUTLIER Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.7 p -135.61 -160.95 1.1 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.561 -0.964 . . . . 0.0 109.975 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.8 mp -138.86 134.07 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.369 -0.832 . . . . 0.0 110.125 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.5 m -93.61 -68.6 0.79 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.56 -0.712 . . . . 0.0 110.065 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.3 p -155.9 -49.78 0.08 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.664 -0.648 . . . . 0.0 109.822 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 14.4 mtmm -65.81 -33.17 75.23 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.655 -0.653 . . . . 0.0 109.687 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -70.06 -29.27 66.24 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.728 -0.607 . . . . 0.0 110.061 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.1 tp -77.41 -20.45 54.6 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.545 -0.722 . . . . 0.0 110.726 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -57.02 -29.69 59.64 Favored Glycine 0 N--CA 1.497 2.757 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -71.86 -29.32 64.26 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.604 -0.939 . . . . 0.0 109.552 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.423 HG21 ' CZ ' ' A' ' 27' ' ' PHE . 58.6 t -66.93 -38.06 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.698 -0.627 . . . . 0.0 109.753 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 9.1 mmt -72.75 -42.38 64.1 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.682 -0.636 . . . . 0.0 109.84 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 19.1 ttp180 -57.67 -24.41 56.55 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.629 -0.669 . . . . 0.0 110.693 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 9.1 ttm -59.64 -51.75 68.49 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.433 -0.792 . . . . 0.0 110.244 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 40.3 mt -62.3 -46.46 88.67 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.523 -0.735 . . . . 0.0 110.093 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 141.59 44.03 0.06 OUTLIER Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.814 -1.315 . . . . 0.0 109.814 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -149.35 141.83 24.33 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.486 -1.008 . . . . 0.0 110.097 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -117.52 74.88 8.89 Favored Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 121.631 -0.668 . . . . 0.0 110.424 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -72.25 178.25 6.28 Favored 'Trans proline' 0 N--CA 1.49 1.314 0 O-C-N 123.871 1.459 . . . . 0.0 110.261 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 19.9 p -97.12 157.4 35.02 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.613 -0.68 . . . . 0.0 110.351 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -69.77 -11.52 30.99 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 O-C-N 123.939 1.494 . . . . 0.0 111.203 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -84.31 -23.26 30.33 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.148 -0.97 . . . . 0.0 110.498 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -85.9 -19.49 30.45 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.438 -0.789 . . . . 0.0 110.755 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 58.5 mt -81.34 -30.11 33.92 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.358 -0.839 . . . . 0.0 110.19 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -57.49 -50.89 71.59 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.572 -0.705 . . . . 0.0 110.714 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.88 -23.1 67.13 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.55 -0.719 . . . . 0.0 110.661 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 27.2 ttp -82.35 -20.31 37.54 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.355 -0.84 . . . . 0.0 111.143 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.9 mt -77.89 -36.7 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.344 -0.847 . . . . 0.0 110.674 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -65.05 -25.92 68.03 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.249 -0.907 . . . . 0.0 110.274 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -81.76 -31.16 32.08 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.489 -0.757 . . . . 0.0 110.19 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 59.0 t -92.96 -41.2 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.583 -0.698 . . . . 0.0 109.931 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -60.87 151.31 30.37 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.621 -0.674 . . . . 0.0 110.259 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -127.38 26.06 6.04 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.531 -0.73 . . . . 0.0 110.403 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -121.47 -53.18 2.01 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.48 -0.763 . . . . 0.0 110.162 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.22 35.37 3.16 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.0 m -103.29 -18.67 14.77 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.617 -0.931 . . . . 0.0 110.777 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.7 29.63 13.18 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 40.5 p -149.82 153.29 36.55 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.565 -0.962 . . . . 0.0 110.224 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 57.6 t -90.74 152.18 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.566 -0.709 . . . . 0.0 109.866 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -122.62 168.3 12.35 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.536 -0.727 . . . . 0.0 110.199 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.4 ' CD1' ' O ' ' A' ' 74' ' ' PHE . 21.5 t80 -54.85 -23.39 18.22 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.506 -0.746 . . . . 0.0 110.754 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -89.54 -58.04 2.66 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.438 -0.788 . . . . 0.0 110.247 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -60.54 -18.78 54.43 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.523 -0.736 . . . . 0.0 111.001 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.502 ' CD1' ' CZ ' ' A' ' 24' ' ' PHE . 12.3 t80 -71.73 -53.89 12.04 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.332 -0.855 . . . . 0.0 110.144 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.2 mt -52.05 -31.57 30.66 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.566 -0.709 . . . . 0.0 110.828 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 64.2 t -60.33 -38.19 76.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.516 -0.74 . . . . 0.0 110.16 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 36.3 mtm -63.77 -27.29 69.09 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.53 -0.731 . . . . 0.0 110.237 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 4.1 mtt -95.73 24.71 5.12 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.507 -0.746 . . . . 0.0 110.449 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 95.6 t -123.49 -40.44 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.532 -0.73 . . . . 0.0 109.438 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -68.16 -18.71 64.69 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.538 -0.726 . . . . 0.0 112.132 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 35.8 m -93.89 111.35 23.04 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 120.43 -0.508 . . . . 0.0 109.801 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 22.8 mtt -59.11 162.86 4.04 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.481 -0.762 . . . . 0.0 110.337 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 8.9 ptpt -83.07 55.66 3.19 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.584 -0.697 . . . . 0.0 110.654 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -171.67 108.6 0.25 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.555 -0.716 . . . . 0.0 110.002 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -88.19 -35.77 17.17 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.426 -0.796 . . . . 0.0 110.021 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 97.2 p -113.1 -30.6 6.93 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.606 -0.684 . . . . 0.0 110.145 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.96 -174.45 0.6 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.58 -0.7 . . . . 7.7699999999999996 110.257 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -161.76 -111.78 0.27 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.317 -1.513 . . . . 2.9399999999999999 109.317 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.37 -175.06 3.74 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.504 -0.998 . . . . 5.7300000000000004 110.413 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 68.6 p 45.87 -92.48 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.855 -0.528 . . . . 3.3199999999999998 111.666 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -64.16 -27.07 68.83 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.967 -1.083 . . . . 2.73 109.571 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -82.63 -22.54 34.68 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.204 -0.935 . . . . 3.1499999999999999 110.721 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -78.8 -29.12 44.71 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.418 -0.802 . . . . 3.29 110.478 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.6 mt -80.84 -26.38 37.06 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.507 -0.746 . . . . 1.3300000000000001 110.802 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 87.9 p -57.3 -22.29 40.88 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.424 -0.797 . . . . 1.8100000000000001 110.964 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -62.7 -30.57 71.51 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.405 -0.81 . . . . 2.1200000000000001 110.638 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.406 ' O ' ' CD1' ' A' ' 104' ' ' PHE . 4.5 mm? -62.28 -29.08 70.17 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.505 -0.747 . . . . 1.8799999999999999 110.23 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.529 ' CE1' ' CD2' ' A' ' 111' ' ' TYR . 0.5 OUTLIER -54.7 -41.19 69.98 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.599 -0.688 . . . . 2.2999999999999998 111.306 -179.393 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 23.0 mtt85 -61.7 -59.64 4.88 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.936 -1.103 . . . . 4.5999999999999996 109.996 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.41 -24.98 65.59 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.691 -0.63 . . . . 2.7000000000000002 110.553 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.44 ' CD2' HD11 ' A' ' 112' ' ' ILE . 5.0 m-85 -80.38 -46.68 15.63 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.581 -0.7 . . . . 2.3500000000000001 110.137 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -82.25 151.51 26.78 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.504 -0.748 . . . . 1.6899999999999999 110.306 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 6.5 mmtt -122.64 -43.68 2.26 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.517 -0.74 . . . . 2.9500000000000002 110.343 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 41.9 p30 -121.78 27.91 7.9 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.56 -0.713 . . . . 2.0800000000000001 110.396 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 53.25 54.17 10.66 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.435 -0.79 . . . . 1.3600000000000001 111.233 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 54.0 p-10 -98.39 -0.65 43.26 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.459 -0.775 . . . . 2.3100000000000001 110.468 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.4 ' O ' ' CZ ' ' A' ' 101' ' ' PHE . . . 132.54 -50.67 0.88 Allowed Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.171 -1.972 . . . . 1.1699999999999999 108.171 -178.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.631 ' HB2' ' HA ' ' A' ' 149' ' ' ASP . 0.9 OUTLIER -173.77 -78.01 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.139 -1.212 . . . . 2.46 111.091 178.581 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.44 HD11 ' CD2' ' A' ' 104' ' ' PHE . 22.3 mt -152.95 149.17 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 CA-C-O 121.705 0.764 . . . . 1.3200000000000001 110.989 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -130.54 -164.5 1.43 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.147 -0.686 . . . . 2.3300000000000001 109.147 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 83.8 mt -65.43 -27.96 68.89 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.339 -0.851 . . . . 2.6499999999999999 111.157 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -93.46 -31.85 14.43 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.36 -0.838 . . . . 2.6000000000000001 111.072 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -78.06 -37.0 47.68 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.446 -0.784 . . . . 1.8600000000000001 110.588 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 20.0 tp -58.34 -25.52 62.05 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.542 -0.724 . . . . 1.7 110.851 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.7 tptm -59.25 -27.32 65.68 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.477 -0.764 . . . . 3.0800000000000001 110.532 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 82.9 mt -78.21 -41.75 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.521 -0.737 . . . . 1.5900000000000001 110.369 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 3.0 ttp -63.96 -29.58 70.74 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.486 -0.759 . . . . 1.98 110.239 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 21.5 mt -79.69 -36.23 37.9 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.574 -0.704 . . . . 2.5600000000000001 110.212 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 33.8 mm-40 -65.54 -31.59 72.72 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.6 -0.687 . . . . 2.3399999999999999 110.104 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -66.87 -32.54 73.88 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.57 -0.706 . . . . 1.5700000000000001 110.432 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 13.5 p -83.47 133.91 34.88 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.539 -0.726 . . . . 1.6799999999999999 110.353 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -65.02 -21.55 67.95 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.145 -1.182 . . . . 1.8400000000000001 110.145 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -52.89 144.16 15.28 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.279 -1.13 . . . . 2.79 110.862 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 19.8 m -71.42 120.47 17.05 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.534 -0.729 . . . . 2.4700000000000002 110.389 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.6 pt -112.02 143.16 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.531 -0.731 . . . . 2.4300000000000002 110.541 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 49.0 p -126.49 -166.46 1.58 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.636 -0.665 . . . . 2.3300000000000001 109.529 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -79.63 -29.85 41.18 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.501 -0.749 . . . . 2.5899999999999999 109.909 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -73.72 -23.13 59.74 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.675 -0.641 . . . . 2.0299999999999998 110.289 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -79.45 -25.28 41.99 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.428 -0.795 . . . . 1.7 110.22 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 49.0 mt -78.46 -47.32 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.416 -0.803 . . . . 1.6000000000000001 109.36 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -61.79 -27.82 69.02 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.601 -0.687 . . . . 2.02 109.819 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -80.44 -25.58 38.86 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.607 -0.683 . . . . 2.8999999999999999 110.13 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.12 -51.08 71.13 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.471 -0.768 . . . . 1.8 109.766 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 9.2 mmt -72.69 -21.33 61.08 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.637 -0.664 . . . . 1.95 110.456 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.9 mttt -58.83 -77.48 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.322 -0.861 . . . . 2.6699999999999999 110.249 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -82.55 -26.8 32.1 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.431 -0.793 . . . . 1.5700000000000001 110.751 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -64.95 -25.88 71.0 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.957 -1.257 . . . . 0.65000000000000002 109.957 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -98.68 138.04 36.42 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.443 -1.033 . . . . 1.47 110.629 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.85 -29.24 10.13 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.664 -0.648 . . . . 2.2799999999999998 109.87 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -97.69 -18.24 18.97 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.567 -0.708 . . . . 2.7000000000000002 110.358 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 34.0 t30 55.64 34.21 22.79 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.243 -0.911 . . . . 2.7999999999999998 110.64 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -77.44 -5.49 50.04 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.553 -0.717 . . . . 1.51 111.128 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 124.57 -29.6 4.93 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.381 -1.487 . . . . 1.03 109.381 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 8.0 ptp85 -136.01 -167.11 1.98 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.504 -0.998 . . . . 2.9900000000000002 109.768 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.572 ' O ' ' HB2' ' A' ' 111' ' ' TYR 0.255 38.8 mm -119.37 -179.86 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 107.27 -1.381 . . . . 1.6599999999999999 107.27 179.488 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.631 ' HA ' ' HB2' ' A' ' 111' ' ' TYR . 3.0 p30 -156.97 165.87 34.97 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-N 118.623 0.647 . . . . 1.52 109.864 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.445 ' N ' ' CD2' ' A' ' 111' ' ' TYR . 27.5 t80 -49.02 -41.43 34.68 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.466 -0.771 . . . . 2.3999999999999999 111.534 -178.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.01 -31.25 69.76 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.511 -0.743 . . . . 1.8300000000000001 110.523 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -84.29 -51.97 6.58 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.453 -0.78 . . . . 1.9099999999999999 110.603 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.415 ' CZ ' ' CG ' ' A' ' 157' ' ' MET . 27.6 t80 -56.91 -20.67 24.58 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.485 -0.759 . . . . 2.54 111.061 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 9.1 mt -56.5 -51.03 70.02 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.277 -0.889 . . . . 2.0699999999999998 110.18 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -79.7 -31.77 41.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.671 -0.643 . . . . 1.98 109.748 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -60.95 -20.79 62.75 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.659 -0.651 . . . . 2.2599999999999998 110.373 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.415 ' CG ' ' CZ ' ' A' ' 153' ' ' PHE . 2.6 mmt -99.74 17.75 19.88 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.347 -0.845 . . . . 1.95 110.917 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 14.3 ttmt -85.0 21.25 1.66 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.25 -0.906 . . . . 3.6099999999999999 111.574 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 106.58 15.84 16.01 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 110.323 -1.111 . . . . 1.6100000000000001 110.323 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 48.2 t -59.54 -58.16 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.261 -1.14 . . . . 2.2000000000000002 110.181 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 . . . . . 0 N--CA 1.494 1.742 0 O-C-N 121.611 -0.681 . . . . 3.6000000000000001 110.217 -179.968 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.5 mmt . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.051 0.453 . . . . 0.0 110.264 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -65.34 92.83 0.13 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.614 -0.679 . . . . 0.0 110.021 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.751 ' O ' ' HB2' ' A' ' 7' ' ' ALA . 4.5 m-20 56.23 107.09 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.584 -0.697 . . . . 0.0 110.71 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 14.9 mt -90.82 -26.14 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.384 -0.822 . . . . 0.0 110.244 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.43 ' HB3' HG13 ' A' ' 79' ' ' VAL . 43.8 m-85 -93.06 -44.41 8.41 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.452 -0.78 . . . . 0.0 110.506 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -77.1 -18.66 57.81 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.614 -0.679 . . . . 0.0 110.888 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.751 ' HB2' ' O ' ' A' ' 3' ' ' ASP . . . -61.26 -54.39 44.7 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.225 -0.922 . . . . 0.0 110.287 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.01 -45.52 92.51 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.578 -0.701 . . . . 0.0 110.118 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.436 ' O ' HD12 ' A' ' 12' ' ' LEU . 62.8 t -58.63 -60.13 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.627 -0.671 . . . . 0.0 109.871 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -60.57 -22.65 63.92 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.505 -0.747 . . . . 0.0 110.011 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -108.0 55.22 0.65 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.54 -0.725 . . . . 0.0 109.874 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.759 HD11 HD13 ' A' ' 78' ' ' LEU . 19.2 mt -90.99 139.05 31.13 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.559 -0.713 . . . . 0.0 110.257 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.1 m -87.04 153.99 21.11 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.565 -0.709 . . . . 0.0 109.648 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -67.4 -24.75 65.7 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.551 -0.718 . . . . 0.0 110.76 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -73.01 -45.86 55.42 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.365 -0.834 . . . . 0.0 110.701 -179.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.585 ' OE1' HD23 ' A' ' 12' ' ' LEU . 9.9 pt20 -74.22 -23.8 59.23 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.361 -0.837 . . . . 0.0 110.323 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.0 tttm -65.51 -44.15 87.86 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.495 -0.753 . . . . 0.0 110.29 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 26.0 p30 -64.49 -21.72 66.75 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.415 -0.803 . . . . 0.0 110.446 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -86.44 -39.67 16.09 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.429 -0.795 . . . . 0.0 109.852 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.404 ' CD2' ' O ' ' A' ' 16' ' ' GLN . 20.7 m-85 -69.27 -36.27 76.92 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.699 -0.626 . . . . 0.0 110.045 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.7 mtpt -55.82 -40.93 73.46 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.506 -0.746 . . . . 0.0 110.423 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.43 -48.51 22.44 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.615 -0.678 . . . . 0.0 109.933 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.403 ' O ' ' CD2' ' A' ' 27' ' ' PHE . . . -62.87 -34.5 77.5 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.661 -0.65 . . . . 0.0 109.915 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.502 ' CZ ' ' CD1' ' A' ' 77' ' ' PHE . 5.7 m-30 -75.53 -29.78 59.56 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.606 -0.684 . . . . 0.0 109.756 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -69.73 -22.24 63.4 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.707 -0.621 . . . . 0.0 110.652 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 41.2 mt -86.82 -38.11 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.305 -0.872 . . . . 0.0 110.198 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.451 ' CE2' HG22 ' A' ' 44' ' ' VAL . 17.0 m-85 -59.33 -22.09 60.76 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.519 -0.738 . . . . 0.0 110.551 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.5 m -95.2 36.4 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.384 -0.822 . . . . 0.0 110.478 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.6 mt -89.91 113.1 24.67 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.442 -0.786 . . . . 0.0 109.976 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 110.36 -29.2 9.34 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.51 -163.73 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.613 -0.934 . . . . 0.0 110.53 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -116.11 -67.58 0.98 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.619 -0.675 . . . . 0.0 110.317 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -73.31 -43.2 61.32 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.547 -0.721 . . . . 0.0 110.225 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 134.74 54.95 0.07 OUTLIER Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.7 p -135.61 -160.95 1.1 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.561 -0.964 . . . . 0.0 109.975 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.795 HG23 ' CB ' ' A' ' 40' ' ' GLU . 4.8 mp -138.86 134.07 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.369 -0.832 . . . . 0.0 110.125 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.549 ' O ' HG23 ' A' ' 38' ' ' THR . 2.5 m -93.61 -68.6 0.79 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.56 -0.712 . . . . 0.0 110.065 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.549 HG23 ' O ' ' A' ' 37' ' ' SER . 3.3 p -155.9 -49.78 0.08 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.664 -0.648 . . . . 0.0 109.822 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 14.4 mtmm -65.81 -33.17 75.23 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.655 -0.653 . . . . 0.0 109.687 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.795 ' CB ' HG23 ' A' ' 36' ' ' ILE . 0.8 OUTLIER -70.06 -29.27 66.24 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.728 -0.607 . . . . 0.0 110.061 179.892 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.1 tp -77.41 -20.45 54.6 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.545 -0.722 . . . . 0.0 110.726 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -57.02 -29.69 59.64 Favored Glycine 0 N--CA 1.497 2.757 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -71.86 -29.32 64.26 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.604 -0.939 . . . . 0.0 109.552 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.451 HG22 ' CE2' ' A' ' 27' ' ' PHE . 58.6 t -66.93 -38.06 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.698 -0.627 . . . . 0.0 109.753 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 9.1 mmt -72.75 -42.38 64.1 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.682 -0.636 . . . . 0.0 109.84 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 19.1 ttp180 -57.67 -24.41 56.55 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.629 -0.669 . . . . 0.0 110.693 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 9.1 ttm -59.64 -51.75 68.49 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.433 -0.792 . . . . 0.0 110.244 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 40.3 mt -62.3 -46.46 88.67 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.523 -0.735 . . . . 0.0 110.093 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 141.59 44.03 0.06 OUTLIER Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.814 -1.315 . . . . 0.0 109.814 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -149.35 141.83 24.33 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.486 -1.008 . . . . 0.0 110.097 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -117.52 74.88 8.89 Favored Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 121.631 -0.668 . . . . 0.0 110.424 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -72.25 178.25 6.28 Favored 'Trans proline' 0 N--CA 1.49 1.314 0 O-C-N 123.871 1.459 . . . . 0.0 110.261 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 19.9 p -97.12 157.4 35.02 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.613 -0.68 . . . . 0.0 110.351 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -69.77 -11.52 30.99 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 O-C-N 123.939 1.494 . . . . 0.0 111.203 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -84.31 -23.26 30.33 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.148 -0.97 . . . . 0.0 110.498 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -85.9 -19.49 30.45 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.438 -0.789 . . . . 0.0 110.755 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 58.5 mt -81.34 -30.11 33.92 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.358 -0.839 . . . . 0.0 110.19 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.711 ' HA ' HD12 ' A' ' 61' ' ' ILE . 30.2 tp60 -57.49 -50.89 71.59 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.572 -0.705 . . . . 0.0 110.714 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.407 ' HA ' ' OD2' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -64.88 -23.1 67.13 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.55 -0.719 . . . . 0.0 110.661 -179.789 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 27.2 ttp -82.35 -20.31 37.54 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.355 -0.84 . . . . 0.0 111.143 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.711 HD12 ' HA ' ' A' ' 58' ' ' GLN . 33.9 mt -77.89 -36.7 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.344 -0.847 . . . . 0.0 110.674 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.407 ' OD2' ' HA ' ' A' ' 59' ' ' GLU . 2.9 p30 -65.05 -25.92 68.03 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.249 -0.907 . . . . 0.0 110.274 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -81.76 -31.16 32.08 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.489 -0.757 . . . . 0.0 110.19 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 59.0 t -92.96 -41.2 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.583 -0.698 . . . . 0.0 109.931 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -60.87 151.31 30.37 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.621 -0.674 . . . . 0.0 110.259 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -127.38 26.06 6.04 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.531 -0.73 . . . . 0.0 110.403 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -121.47 -53.18 2.01 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.48 -0.763 . . . . 0.0 110.162 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.22 35.37 3.16 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.0 m -103.29 -18.67 14.77 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.617 -0.931 . . . . 0.0 110.777 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.44 ' C ' HG23 ' A' ' 71' ' ' THR . . . 90.7 29.63 13.18 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.44 HG23 ' C ' ' A' ' 70' ' ' GLY . 40.5 p -149.82 153.29 36.55 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.565 -0.962 . . . . 0.0 110.224 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 57.6 t -90.74 152.18 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.566 -0.709 . . . . 0.0 109.866 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -122.62 168.3 12.35 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.536 -0.727 . . . . 0.0 110.199 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.4 ' CD1' ' O ' ' A' ' 74' ' ' PHE . 21.5 t80 -54.85 -23.39 18.22 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.506 -0.746 . . . . 0.0 110.754 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -89.54 -58.04 2.66 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.438 -0.788 . . . . 0.0 110.247 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -60.54 -18.78 54.43 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.523 -0.736 . . . . 0.0 111.001 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.502 ' CD1' ' CZ ' ' A' ' 24' ' ' PHE . 12.3 t80 -71.73 -53.89 12.04 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.332 -0.855 . . . . 0.0 110.144 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.759 HD13 HD11 ' A' ' 12' ' ' LEU . 40.2 mt -52.05 -31.57 30.66 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.566 -0.709 . . . . 0.0 110.828 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.43 HG13 ' HB3' ' A' ' 5' ' ' TYR . 64.2 t -60.33 -38.19 76.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.516 -0.74 . . . . 0.0 110.16 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 36.3 mtm -63.77 -27.29 69.09 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.53 -0.731 . . . . 0.0 110.237 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 4.1 mtt -95.73 24.71 5.12 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.507 -0.746 . . . . 0.0 110.449 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.737 HG23 ' O ' ' A' ' 78' ' ' LEU . 95.6 t -123.49 -40.44 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.532 -0.73 . . . . 0.0 109.438 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -68.16 -18.71 64.69 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.538 -0.726 . . . . 0.0 112.132 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 35.8 m -93.89 111.35 23.04 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 120.43 -0.508 . . . . 0.0 109.801 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 22.8 mtt -59.11 162.86 4.04 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.481 -0.762 . . . . 0.0 110.337 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 8.9 ptpt -83.07 55.66 3.19 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.584 -0.697 . . . . 0.0 110.654 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -171.67 108.6 0.25 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.555 -0.716 . . . . 0.0 110.002 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -88.19 -35.77 17.17 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.426 -0.796 . . . . 0.0 110.021 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 97.2 p -113.1 -30.6 6.93 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.606 -0.684 . . . . 0.0 110.145 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.96 -174.45 0.6 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.58 -0.7 . . . . 7.23 110.257 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -161.76 -111.78 0.27 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.317 -1.513 . . . . 2.45 109.317 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.37 -175.06 3.74 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.504 -0.998 . . . . 5.31 110.413 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 68.6 p 45.87 -92.48 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.855 -0.528 . . . . 2.84 111.666 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -64.16 -27.07 68.83 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.967 -1.083 . . . . 2.73 109.571 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -82.63 -22.54 34.68 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.204 -0.935 . . . . 3.15 110.721 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -78.8 -29.12 44.71 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.418 -0.802 . . . . 3.29 110.478 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.6 mt -80.84 -26.38 37.06 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.507 -0.746 . . . . 1.24 110.802 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 87.9 p -57.3 -22.29 40.88 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.424 -0.797 . . . . 1.5 110.964 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -62.7 -30.57 71.51 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.405 -0.81 . . . . 2.12 110.638 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.491 HD22 ' N ' ' A' ' 100' ' ' LEU . 4.5 mm? -62.28 -29.08 70.17 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.505 -0.747 . . . . 1.52 110.23 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.529 ' CE1' ' CD2' ' A' ' 111' ' ' TYR . 0.5 OUTLIER -54.7 -41.19 69.98 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.599 -0.688 . . . . 1.44 111.306 -179.393 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 23.0 mtt85 -61.7 -59.64 4.88 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.936 -1.103 . . . . 4.02 109.996 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.41 -24.98 65.59 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.691 -0.63 . . . . 2.14 110.553 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.602 ' CD2' HD11 ' A' ' 112' ' ' ILE . 5.0 m-85 -80.38 -46.68 15.63 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.581 -0.7 . . . . 1.5 110.137 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -82.25 151.51 26.78 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.504 -0.748 . . . . 1.69 110.306 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 6.5 mmtt -122.64 -43.68 2.26 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.517 -0.74 . . . . 2.45 110.343 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 41.9 p30 -121.78 27.91 7.9 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.56 -0.713 . . . . 1.8 110.396 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 53.25 54.17 10.66 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.435 -0.79 . . . . 1.36 111.233 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 54.0 p-10 -98.39 -0.65 43.26 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.459 -0.775 . . . . 2.31 110.468 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.4 ' O ' ' CZ ' ' A' ' 101' ' ' PHE . . . 132.54 -50.67 0.88 Allowed Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.171 -1.972 . . . . 1.11 108.171 -178.217 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.639 ' HB2' ' HA ' ' A' ' 149' ' ' ASP . 0.9 OUTLIER -173.77 -78.01 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.139 -1.212 . . . . 1.72 111.091 178.581 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.602 HD11 ' CD2' ' A' ' 104' ' ' PHE . 22.3 mt -152.95 149.17 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 CA-C-O 121.705 0.764 . . . . 0.74 110.989 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -130.54 -164.5 1.43 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.147 -0.686 . . . . 2.33 109.147 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 83.8 mt -65.43 -27.96 68.89 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.339 -0.851 . . . . 2.05 111.157 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -93.46 -31.85 14.43 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.36 -0.838 . . . . 2.6 111.072 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.422 ' HB3' HG23 ' A' ' 112' ' ' ILE . 4.5 tt0 -78.06 -37.0 47.68 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.446 -0.784 . . . . 1.86 110.588 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.87 HD23 HG23 ' A' ' 133' ' ' ILE . 20.0 tp -58.34 -25.52 62.05 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.542 -0.724 . . . . 1.27 110.851 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.7 tptm -59.25 -27.32 65.68 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.477 -0.764 . . . . 2.66 110.532 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 82.9 mt -78.21 -41.75 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.521 -0.737 . . . . 1.12 110.369 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 3.0 ttp -63.96 -29.58 70.74 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.486 -0.759 . . . . 1.56 110.239 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.716 ' HB3' HD13 ' A' ' 128' ' ' ILE . 21.5 mt -79.69 -36.23 37.9 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.574 -0.704 . . . . 2.04 110.212 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 33.8 mm-40 -65.54 -31.59 72.72 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.6 -0.687 . . . . 2.24 110.104 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -66.87 -32.54 73.88 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.57 -0.706 . . . . 1.23 110.432 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 13.5 p -83.47 133.91 34.88 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.539 -0.726 . . . . 1.29 110.353 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -65.02 -21.55 67.95 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.145 -1.182 . . . . 1.84 110.145 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -52.89 144.16 15.28 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.279 -1.13 . . . . 2.79 110.862 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 19.8 m -71.42 120.47 17.05 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.534 -0.729 . . . . 2.16 110.389 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.716 HD13 ' HB3' ' A' ' 121' ' ' LEU . 1.6 pt -112.02 143.16 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.531 -0.731 . . . . 1.79 110.541 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 49.0 p -126.49 -166.46 1.58 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.636 -0.665 . . . . 1.92 109.529 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.6 ' HA ' HD12 ' A' ' 133' ' ' ILE . 24.4 mm-40 -79.63 -29.85 41.18 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.501 -0.749 . . . . 2.59 109.909 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -73.72 -23.13 59.74 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.675 -0.641 . . . . 2.03 110.289 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.8 ' O ' HD23 ' A' ' 136' ' ' LEU . 28.8 m-20 -79.45 -25.28 41.99 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.428 -0.795 . . . . 1.7 110.22 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.87 HG23 HD23 ' A' ' 117' ' ' LEU . 49.0 mt -78.46 -47.32 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.416 -0.803 . . . . 1.22 109.36 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -61.79 -27.82 69.02 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.601 -0.687 . . . . 2.02 109.819 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -80.44 -25.58 38.86 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.607 -0.683 . . . . 2.9 110.13 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.8 HD23 ' O ' ' A' ' 132' ' ' ASP . 0.8 OUTLIER -60.12 -51.08 71.13 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.471 -0.768 . . . . 1.1 109.766 179.668 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 9.2 mmt -72.69 -21.33 61.08 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.637 -0.664 . . . . 1.33 110.456 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.9 mttt -58.83 -77.48 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.322 -0.861 . . . . 2.23 110.249 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -82.55 -26.8 32.1 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.431 -0.793 . . . . 1.57 110.751 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -64.95 -25.88 71.0 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.957 -1.257 . . . . 0.65 109.957 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.432 ' HB2' HD11 ' A' ' 148' ' ' ILE . 15.5 t0 -98.68 138.04 36.42 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.443 -1.033 . . . . 1.47 110.629 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.85 -29.24 10.13 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.664 -0.648 . . . . 1.81 109.87 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -97.69 -18.24 18.97 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.567 -0.708 . . . . 2.15 110.358 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 34.0 t30 55.64 34.21 22.79 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.243 -0.911 . . . . 2.34 110.64 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -77.44 -5.49 50.04 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.553 -0.717 . . . . 1.51 111.128 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 124.57 -29.6 4.93 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.381 -1.487 . . . . 0.93 109.381 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 8.0 ptp85 -136.01 -167.11 1.98 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.504 -0.998 . . . . 2.5 109.768 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.636 ' O ' ' HB2' ' A' ' 111' ' ' TYR 0.255 38.8 mm -119.37 -179.86 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 107.27 -1.381 . . . . 1.01 107.27 179.488 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.639 ' HA ' ' HB2' ' A' ' 111' ' ' TYR . 3.0 p30 -156.97 165.87 34.97 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-N 118.623 0.647 . . . . 1.52 109.864 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.445 ' N ' ' CD2' ' A' ' 111' ' ' TYR . 27.5 t80 -49.02 -41.43 34.68 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.466 -0.771 . . . . 1.6 111.534 -178.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.407 ' HA ' HD12 ' A' ' 154' ' ' LEU . 1.1 m-20 -60.01 -31.25 69.76 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.511 -0.743 . . . . 1.83 110.523 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -84.29 -51.97 6.58 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.453 -0.78 . . . . 1.91 110.603 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.44 ' CE2' ' HG3' ' A' ' 157' ' ' MET . 27.6 t80 -56.91 -20.67 24.58 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.485 -0.759 . . . . 1.67 111.061 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 151' ' ' ASP . 9.1 mt -56.5 -51.03 70.02 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.277 -0.889 . . . . 1.63 110.18 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -79.7 -31.77 41.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.671 -0.643 . . . . 1.98 109.748 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -60.95 -20.79 62.75 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.659 -0.651 . . . . 1.39 110.373 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.44 ' HG3' ' CE2' ' A' ' 153' ' ' PHE . 2.6 mmt -99.74 17.75 19.88 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.347 -0.845 . . . . 1.5 110.917 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 14.3 ttmt -85.0 21.25 1.66 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.25 -0.906 . . . . 3.18 111.574 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 106.58 15.84 16.01 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 110.323 -1.111 . . . . 1.56 110.323 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 48.2 t -59.54 -58.16 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.261 -1.14 . . . . 1.85 110.181 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 . . . . . 0 N--CA 1.494 1.742 0 O-C-N 121.611 -0.681 . . . . 3.6 110.217 -179.968 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.5 mmt . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.051 0.453 . . . . 0.0 110.264 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -65.34 92.83 0.13 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.614 -0.679 . . . . 0.0 110.021 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.751 ' O ' ' HB2' ' A' ' 7' ' ' ALA . 4.5 m-20 56.23 107.09 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.584 -0.697 . . . . 0.0 110.71 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 14.9 mt -90.82 -26.14 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.384 -0.822 . . . . 0.0 110.244 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.43 ' HB3' HG13 ' A' ' 79' ' ' VAL . 43.8 m-85 -93.06 -44.41 8.41 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.452 -0.78 . . . . 0.0 110.506 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -77.1 -18.66 57.81 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.614 -0.679 . . . . 0.0 110.888 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.751 ' HB2' ' O ' ' A' ' 3' ' ' ASP . . . -61.26 -54.39 44.7 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.225 -0.922 . . . . 0.0 110.287 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.01 -45.52 92.51 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.578 -0.701 . . . . 0.0 110.118 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.436 ' O ' HD12 ' A' ' 12' ' ' LEU . 62.8 t -58.63 -60.13 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.627 -0.671 . . . . 0.0 109.871 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -60.57 -22.65 63.92 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.505 -0.747 . . . . 0.0 110.011 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -108.0 55.22 0.65 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.54 -0.725 . . . . 0.0 109.874 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.759 HD11 HD13 ' A' ' 78' ' ' LEU . 19.2 mt -90.99 139.05 31.13 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.559 -0.713 . . . . 0.0 110.257 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.1 m -87.04 153.99 21.11 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.565 -0.709 . . . . 0.0 109.648 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -67.4 -24.75 65.7 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.551 -0.718 . . . . 0.0 110.76 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -73.01 -45.86 55.42 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.365 -0.834 . . . . 0.0 110.701 -179.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.585 ' OE1' HD23 ' A' ' 12' ' ' LEU . 9.9 pt20 -74.22 -23.8 59.23 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.361 -0.837 . . . . 0.0 110.323 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.0 tttm -65.51 -44.15 87.86 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.495 -0.753 . . . . 0.0 110.29 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 26.0 p30 -64.49 -21.72 66.75 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.415 -0.803 . . . . 0.0 110.446 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -86.44 -39.67 16.09 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.429 -0.795 . . . . 0.0 109.852 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.404 ' CD2' ' O ' ' A' ' 16' ' ' GLN . 20.7 m-85 -69.27 -36.27 76.92 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.699 -0.626 . . . . 0.0 110.045 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.7 mtpt -55.82 -40.93 73.46 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.506 -0.746 . . . . 0.0 110.423 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.43 -48.51 22.44 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.615 -0.678 . . . . 0.0 109.933 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.403 ' O ' ' CD2' ' A' ' 27' ' ' PHE . . . -62.87 -34.5 77.5 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.661 -0.65 . . . . 0.0 109.915 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.502 ' CZ ' ' CD1' ' A' ' 77' ' ' PHE . 5.7 m-30 -75.53 -29.78 59.56 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.606 -0.684 . . . . 0.0 109.756 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -69.73 -22.24 63.4 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.707 -0.621 . . . . 0.0 110.652 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 41.2 mt -86.82 -38.11 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.305 -0.872 . . . . 0.0 110.198 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.451 ' CE2' HG22 ' A' ' 44' ' ' VAL . 17.0 m-85 -59.33 -22.09 60.76 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.519 -0.738 . . . . 0.0 110.551 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.5 m -95.2 36.4 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.384 -0.822 . . . . 0.0 110.478 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.6 mt -89.91 113.1 24.67 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.442 -0.786 . . . . 0.0 109.976 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 110.36 -29.2 9.34 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.51 -163.73 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.613 -0.934 . . . . 0.0 110.53 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -116.11 -67.58 0.98 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.619 -0.675 . . . . 0.0 110.317 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -73.31 -43.2 61.32 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.547 -0.721 . . . . 0.0 110.225 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 134.74 54.95 0.07 OUTLIER Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.7 p -135.61 -160.95 1.1 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.561 -0.964 . . . . 0.0 109.975 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.795 HG23 ' CB ' ' A' ' 40' ' ' GLU . 4.8 mp -138.86 134.07 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.369 -0.832 . . . . 0.0 110.125 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.549 ' O ' HG23 ' A' ' 38' ' ' THR . 2.5 m -93.61 -68.6 0.79 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.56 -0.712 . . . . 0.0 110.065 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.549 HG23 ' O ' ' A' ' 37' ' ' SER . 3.3 p -155.9 -49.78 0.08 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.664 -0.648 . . . . 0.0 109.822 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 14.4 mtmm -65.81 -33.17 75.23 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.655 -0.653 . . . . 0.0 109.687 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.795 ' CB ' HG23 ' A' ' 36' ' ' ILE . 0.8 OUTLIER -70.06 -29.27 66.24 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.728 -0.607 . . . . 0.0 110.061 179.892 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.1 tp -77.41 -20.45 54.6 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.545 -0.722 . . . . 0.0 110.726 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -57.02 -29.69 59.64 Favored Glycine 0 N--CA 1.497 2.757 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -71.86 -29.32 64.26 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.604 -0.939 . . . . 0.0 109.552 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.451 HG22 ' CE2' ' A' ' 27' ' ' PHE . 58.6 t -66.93 -38.06 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.698 -0.627 . . . . 0.0 109.753 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 9.1 mmt -72.75 -42.38 64.1 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.682 -0.636 . . . . 0.0 109.84 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 19.1 ttp180 -57.67 -24.41 56.55 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.629 -0.669 . . . . 0.0 110.693 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 9.1 ttm -59.64 -51.75 68.49 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.433 -0.792 . . . . 0.0 110.244 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 40.3 mt -62.3 -46.46 88.67 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.523 -0.735 . . . . 0.0 110.093 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 141.59 44.03 0.06 OUTLIER Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.814 -1.315 . . . . 0.0 109.814 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -149.35 141.83 24.33 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.486 -1.008 . . . . 0.0 110.097 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -117.52 74.88 8.89 Favored Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 121.631 -0.668 . . . . 0.0 110.424 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -72.25 178.25 6.28 Favored 'Trans proline' 0 N--CA 1.49 1.314 0 O-C-N 123.871 1.459 . . . . 0.0 110.261 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 19.9 p -97.12 157.4 35.02 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.613 -0.68 . . . . 0.0 110.351 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -69.77 -11.52 30.99 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 O-C-N 123.939 1.494 . . . . 0.0 111.203 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -84.31 -23.26 30.33 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.148 -0.97 . . . . 0.0 110.498 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -85.9 -19.49 30.45 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.438 -0.789 . . . . 0.0 110.755 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 58.5 mt -81.34 -30.11 33.92 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.358 -0.839 . . . . 0.0 110.19 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.711 ' HA ' HD12 ' A' ' 61' ' ' ILE . 30.2 tp60 -57.49 -50.89 71.59 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.572 -0.705 . . . . 0.0 110.714 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.407 ' HA ' ' OD2' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -64.88 -23.1 67.13 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.55 -0.719 . . . . 0.0 110.661 -179.789 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 27.2 ttp -82.35 -20.31 37.54 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.355 -0.84 . . . . 0.0 111.143 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.711 HD12 ' HA ' ' A' ' 58' ' ' GLN . 33.9 mt -77.89 -36.7 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.344 -0.847 . . . . 0.0 110.674 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.407 ' OD2' ' HA ' ' A' ' 59' ' ' GLU . 2.9 p30 -65.05 -25.92 68.03 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.249 -0.907 . . . . 0.0 110.274 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -81.76 -31.16 32.08 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.489 -0.757 . . . . 0.0 110.19 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 59.0 t -92.96 -41.2 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.583 -0.698 . . . . 0.0 109.931 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -60.87 151.31 30.37 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.621 -0.674 . . . . 0.0 110.259 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -127.38 26.06 6.04 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.531 -0.73 . . . . 0.0 110.403 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -121.47 -53.18 2.01 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.48 -0.763 . . . . 0.0 110.162 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.22 35.37 3.16 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.0 m -103.29 -18.67 14.77 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.617 -0.931 . . . . 0.0 110.777 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.44 ' C ' HG23 ' A' ' 71' ' ' THR . . . 90.7 29.63 13.18 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.44 HG23 ' C ' ' A' ' 70' ' ' GLY . 40.5 p -149.82 153.29 36.55 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.565 -0.962 . . . . 0.0 110.224 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 57.6 t -90.74 152.18 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.566 -0.709 . . . . 0.0 109.866 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -122.62 168.3 12.35 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.536 -0.727 . . . . 0.0 110.199 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.4 ' CD1' ' O ' ' A' ' 74' ' ' PHE . 21.5 t80 -54.85 -23.39 18.22 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.506 -0.746 . . . . 0.0 110.754 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -89.54 -58.04 2.66 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.438 -0.788 . . . . 0.0 110.247 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -60.54 -18.78 54.43 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.523 -0.736 . . . . 0.0 111.001 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.502 ' CD1' ' CZ ' ' A' ' 24' ' ' PHE . 12.3 t80 -71.73 -53.89 12.04 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.332 -0.855 . . . . 0.0 110.144 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.759 HD13 HD11 ' A' ' 12' ' ' LEU . 40.2 mt -52.05 -31.57 30.66 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.566 -0.709 . . . . 0.0 110.828 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.43 HG13 ' HB3' ' A' ' 5' ' ' TYR . 64.2 t -60.33 -38.19 76.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.516 -0.74 . . . . 0.0 110.16 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 36.3 mtm -63.77 -27.29 69.09 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.53 -0.731 . . . . 0.0 110.237 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 4.1 mtt -95.73 24.71 5.12 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.507 -0.746 . . . . 0.0 110.449 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.737 HG23 ' O ' ' A' ' 78' ' ' LEU . 95.6 t -123.49 -40.44 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.532 -0.73 . . . . 0.0 109.438 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -68.16 -18.71 64.69 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.538 -0.726 . . . . 0.0 112.132 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 35.8 m -93.89 111.35 23.04 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 120.43 -0.508 . . . . 0.0 109.801 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 22.8 mtt -59.11 162.86 4.04 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.481 -0.762 . . . . 0.0 110.337 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 8.9 ptpt -83.07 55.66 3.19 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.584 -0.697 . . . . 0.0 110.654 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -171.67 108.6 0.25 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.555 -0.716 . . . . 0.0 110.002 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -88.19 -35.77 17.17 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.426 -0.796 . . . . 0.0 110.021 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 97.2 p -113.1 -30.6 6.93 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.606 -0.684 . . . . 0.0 110.145 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.96 -174.45 0.6 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.58 -0.7 . . . . 7.23 110.257 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -161.76 -111.78 0.27 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.317 -1.513 . . . . 2.45 109.317 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.37 -175.06 3.74 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.504 -0.998 . . . . 5.31 110.413 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 68.6 p 45.87 -92.48 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.855 -0.528 . . . . 2.84 111.666 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -64.16 -27.07 68.83 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.967 -1.083 . . . . 2.73 109.571 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -82.63 -22.54 34.68 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.204 -0.935 . . . . 3.15 110.721 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -78.8 -29.12 44.71 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.418 -0.802 . . . . 3.29 110.478 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.6 mt -80.84 -26.38 37.06 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.507 -0.746 . . . . 1.24 110.802 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 87.9 p -57.3 -22.29 40.88 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.424 -0.797 . . . . 1.5 110.964 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -62.7 -30.57 71.51 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.405 -0.81 . . . . 2.12 110.638 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.491 HD22 ' N ' ' A' ' 100' ' ' LEU . 4.5 mm? -62.28 -29.08 70.17 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.505 -0.747 . . . . 1.52 110.23 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.529 ' CE1' ' CD2' ' A' ' 111' ' ' TYR . 0.5 OUTLIER -54.7 -41.19 69.98 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.599 -0.688 . . . . 1.44 111.306 -179.393 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 23.0 mtt85 -61.7 -59.64 4.88 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.936 -1.103 . . . . 4.02 109.996 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.41 -24.98 65.59 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.691 -0.63 . . . . 2.14 110.553 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.602 ' CD2' HD11 ' A' ' 112' ' ' ILE . 5.0 m-85 -80.38 -46.68 15.63 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.581 -0.7 . . . . 1.5 110.137 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -82.25 151.51 26.78 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.504 -0.748 . . . . 1.69 110.306 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 6.5 mmtt -122.64 -43.68 2.26 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.517 -0.74 . . . . 2.45 110.343 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 41.9 p30 -121.78 27.91 7.9 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.56 -0.713 . . . . 1.8 110.396 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 53.25 54.17 10.66 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.435 -0.79 . . . . 1.36 111.233 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 54.0 p-10 -98.39 -0.65 43.26 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.459 -0.775 . . . . 2.31 110.468 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.4 ' O ' ' CZ ' ' A' ' 101' ' ' PHE . . . 132.54 -50.67 0.88 Allowed Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.171 -1.972 . . . . 1.11 108.171 -178.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.639 ' HB2' ' HA ' ' A' ' 149' ' ' ASP . 0.9 OUTLIER -173.77 -78.01 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.139 -1.212 . . . . 1.72 111.091 178.581 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.602 HD11 ' CD2' ' A' ' 104' ' ' PHE . 22.3 mt -152.95 149.17 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 CA-C-O 121.705 0.764 . . . . 0.74 110.989 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -130.54 -164.5 1.43 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.147 -0.686 . . . . 2.33 109.147 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 83.8 mt -65.43 -27.96 68.89 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.339 -0.851 . . . . 2.05 111.157 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -93.46 -31.85 14.43 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.36 -0.838 . . . . 2.6 111.072 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.422 ' HB3' HG23 ' A' ' 112' ' ' ILE . 4.5 tt0 -78.06 -37.0 47.68 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.446 -0.784 . . . . 1.86 110.588 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.87 HD23 HG23 ' A' ' 133' ' ' ILE . 20.0 tp -58.34 -25.52 62.05 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.542 -0.724 . . . . 1.27 110.851 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.7 tptm -59.25 -27.32 65.68 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.477 -0.764 . . . . 2.66 110.532 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 82.9 mt -78.21 -41.75 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.521 -0.737 . . . . 1.12 110.369 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 3.0 ttp -63.96 -29.58 70.74 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.486 -0.759 . . . . 1.56 110.239 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.716 ' HB3' HD13 ' A' ' 128' ' ' ILE . 21.5 mt -79.69 -36.23 37.9 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.574 -0.704 . . . . 2.04 110.212 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 33.8 mm-40 -65.54 -31.59 72.72 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.6 -0.687 . . . . 2.24 110.104 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -66.87 -32.54 73.88 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.57 -0.706 . . . . 1.23 110.432 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 13.5 p -83.47 133.91 34.88 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.539 -0.726 . . . . 1.29 110.353 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -65.02 -21.55 67.95 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.145 -1.182 . . . . 1.84 110.145 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -52.89 144.16 15.28 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.279 -1.13 . . . . 2.79 110.862 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 19.8 m -71.42 120.47 17.05 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.534 -0.729 . . . . 2.16 110.389 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.716 HD13 ' HB3' ' A' ' 121' ' ' LEU . 1.6 pt -112.02 143.16 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.531 -0.731 . . . . 1.79 110.541 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 49.0 p -126.49 -166.46 1.58 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.636 -0.665 . . . . 1.92 109.529 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.6 ' HA ' HD12 ' A' ' 133' ' ' ILE . 24.4 mm-40 -79.63 -29.85 41.18 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.501 -0.749 . . . . 2.59 109.909 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -73.72 -23.13 59.74 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.675 -0.641 . . . . 2.03 110.289 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.8 ' O ' HD23 ' A' ' 136' ' ' LEU . 28.8 m-20 -79.45 -25.28 41.99 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.428 -0.795 . . . . 1.7 110.22 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.87 HG23 HD23 ' A' ' 117' ' ' LEU . 49.0 mt -78.46 -47.32 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.416 -0.803 . . . . 1.22 109.36 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -61.79 -27.82 69.02 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.601 -0.687 . . . . 2.02 109.819 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -80.44 -25.58 38.86 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.607 -0.683 . . . . 2.9 110.13 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.8 HD23 ' O ' ' A' ' 132' ' ' ASP . 0.8 OUTLIER -60.12 -51.08 71.13 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.471 -0.768 . . . . 1.1 109.766 179.668 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 9.2 mmt -72.69 -21.33 61.08 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.637 -0.664 . . . . 1.33 110.456 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.9 mttt -58.83 -77.48 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.322 -0.861 . . . . 2.23 110.249 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -82.55 -26.8 32.1 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.431 -0.793 . . . . 1.57 110.751 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -64.95 -25.88 71.0 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.957 -1.257 . . . . 0.65 109.957 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.432 ' HB2' HD11 ' A' ' 148' ' ' ILE . 15.5 t0 -98.68 138.04 36.42 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.443 -1.033 . . . . 1.47 110.629 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.85 -29.24 10.13 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.664 -0.648 . . . . 1.81 109.87 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -97.69 -18.24 18.97 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.567 -0.708 . . . . 2.15 110.358 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 34.0 t30 55.64 34.21 22.79 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.243 -0.911 . . . . 2.34 110.64 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -77.44 -5.49 50.04 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.553 -0.717 . . . . 1.51 111.128 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 124.57 -29.6 4.93 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.381 -1.487 . . . . 0.93 109.381 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 8.0 ptp85 -136.01 -167.11 1.98 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.504 -0.998 . . . . 2.5 109.768 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.636 ' O ' ' HB2' ' A' ' 111' ' ' TYR 0.255 38.8 mm -119.37 -179.86 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 107.27 -1.381 . . . . 1.01 107.27 179.488 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.639 ' HA ' ' HB2' ' A' ' 111' ' ' TYR . 3.0 p30 -156.97 165.87 34.97 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-N 118.623 0.647 . . . . 1.52 109.864 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.445 ' N ' ' CD2' ' A' ' 111' ' ' TYR . 27.5 t80 -49.02 -41.43 34.68 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.466 -0.771 . . . . 1.6 111.534 -178.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.407 ' HA ' HD12 ' A' ' 154' ' ' LEU . 1.1 m-20 -60.01 -31.25 69.76 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.511 -0.743 . . . . 1.83 110.523 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -84.29 -51.97 6.58 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.453 -0.78 . . . . 1.91 110.603 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.44 ' CE2' ' HG3' ' A' ' 157' ' ' MET . 27.6 t80 -56.91 -20.67 24.58 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.485 -0.759 . . . . 1.67 111.061 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 151' ' ' ASP . 9.1 mt -56.5 -51.03 70.02 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.277 -0.889 . . . . 1.63 110.18 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -79.7 -31.77 41.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.671 -0.643 . . . . 1.98 109.748 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -60.95 -20.79 62.75 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.659 -0.651 . . . . 1.39 110.373 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.44 ' HG3' ' CE2' ' A' ' 153' ' ' PHE . 2.6 mmt -99.74 17.75 19.88 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.347 -0.845 . . . . 1.5 110.917 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 14.3 ttmt -85.0 21.25 1.66 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.25 -0.906 . . . . 3.18 111.574 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 106.58 15.84 16.01 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 110.323 -1.111 . . . . 1.56 110.323 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 48.2 t -59.54 -58.16 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.261 -1.14 . . . . 1.85 110.181 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 . . . . . 0 N--CA 1.494 1.742 0 O-C-N 121.611 -0.681 . . . . 3.6 110.217 -179.968 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_